To the Editor Somatic comorbidities, including diabetes and cardiovascular disease are key contributors to premature mortality in people with mental illness. The mental-physical divide within psychiatric care is eroding, and a growing number of successful lifestyle interventions targeting this population are emerging. However, staff culture can be a formidable barrier to achieving integration of physical health programmes as a core component of mental health services. Health professionals engaged in healthy lifestyle behaviours themselves are more likely to promote such behaviours among their patients (Fie et al., 2013) , which is more likely to impact long-term behaviour change. Hjorth et al. demonstrated that an intervention promoting physical health among staff of mental health facilities impacted upon patient physical health (Hjorth et al., 2015) . Staff who participated in the study improved key measures of cardiometabolic risk, achieving reductions in their own waist circumferences, while noting that the staff had acted as positive role models for patient behaviour change. Following the successful implementation and integration of a multi-disciplinary lifestyle intervention for patients of the Bondi Early Psychosis Program (Keeping the Body in Mind [KBIM] programme) at South Eastern Sydney Local Health District in 2014 (Curtis et al., in press), funding was provided for District-wide implementation of KBIM. An investment in the mental health workforce, to build capacity and initiate culture change, was developed -'Keeping our Staff in Mind' (KoSiM). Staff were offered first-hand experience of the KBIM physical health assessment and a brief individualised lifestyle intervention programme. It was hypothesised that KoSiM would be a catalyst for building capacity in the workforce and facilitating culture change, with the aim of improving the physical health of mental health consumers. Specifically, KoSiM aimed to develop staff 'champions' to drive the District-wide KBIM implementation while identifying and addressing potential barriers that prevent staff from addressing the physical health of consumers, such as lack of knowledge or confidence. An additional potential benefit of the KoSiM initiative is an improvement in staff wellbeing. Of 702 potential participants (existing mental health staff), 204 (29%) completed a baseline survey, and 154 staff agreed to participate in the 4-week individualised lifestyle intervention. The HeAL declaration (www.iphys.org.au) challenges health professionals and organisations to maintain and protect the physical health of people experiencing psychosis. The KoSiM programme is a first step towards system-wide implementation and integration of comprehensive physical health care for this high-risk population.
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The authors received no financial support for the research, authorship and/or publication of this article. Intervention to promote physical health in staff within mental health facilities and the impact on patients' physical health. Nordic Journal of Psychiatry 18: 1-10. To the Editor Cotard's syndrome is a rare neuropsychiatric condition which is characterized by nihilistic delusions. There are several neuroimaging studies showing different kinds of brain abnormalities in Cotard's syndrome. However, 18 F-fluorodeoxyglucosepositron emission tomography ( 18 F-FDG PET) scanning has rarely been performed in patients with Cotard's syndrome (Charland-Verville et al., 2013) . Here, we present the first case report of a patient with Cotard's syndrome in whom hypermetabolism in the basal ganglia has been identified.
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A 48-year-old man with schizophrenia was brought to the emergency department by his sister for aggression and thoughts of being dead. Laboratory work-up was normal, and computed tomography (CT) scan showed mild frontal lobe atrophy. He was being prescribed amisulpride 800 mg/day and sertraline 100 mg/day. Neurologic examination revealed cogwheel rigidity in his upper extremities. Because of extrapyramidal system side effects, amisulpride was gradually withdrawn and quetiapine 600 mg/day was started and then increased up to 900 mg/day. Lorazepam 2 mg/day was added to his medication, but no clinical improvement was observed. After 3 weeks of treatment, he was still agitated and his delusions remained. In order to exclude an organic cause, an electroencephalography examination was performed and the findings were normal. Then, 18 F-FDG PET imaging was performed, and in three-dimensional stereotactic surface projection analysis, hypometabolism in the frontalparietal-temporal association cortex, moderate reduction in the cerebellum and severe focal decrease in the left frontal operculum were detected. However notably, hypermetabolic activity was observed in the basal ganglia area (Figure 1) .
Because of the lack of response to medication, 14 sessions of bitemporal electroconvulsive therapy (ECT) were performed (TM of Somatics, Inc., Lake Bluff). After ECT treatment, his symptoms were improved and he was discharged from hospital. At 6-month follow-up, it was reported that he was still in remission and functioning well.
Here, we report a patient with Cotard's syndrome in the context of schizophrenia, showing brain metabolism abnormalities in 18 F-PDG PET scan and treated with ECT successfully. This report provides new insights regarding possible structural and functional brain abnormalities related to Cotard's syndrome (Debruyne et al., 2011) : hypometabolism in the frontalparietal-temporal association cortex and hypermetabolism in the basal ganglia might be related to the pathophysiology of the illness and ECT could be first-line treatment in Cotard's syndrome.
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